FDA warning letters, a supplement class action lawsuit, and the exact GLP-1 ad claims now triggering compliance risk, plus compliant reframes supplement brands can use instead.
A plain-English breakdown of DSHEA structure/function claims vs. disease claims, the required FDA disclaimer, the FTC's separate substantiation standard, and what's changing in supplement ad compliance in 2026.
FTC's revised Endorsement Guides and new Consumer Review Rule are being enforced against supplement brands in 2026. Here is what your UGC and influencer disclosures must say, what brands are liable for, and the pre-launch checklist to avoid penalties.
Copyright 2026. eBrandX. All Rights Reserved.
